SeroClear

Reducing the burden of sugar-driven aging

  • Stage Product In Development
  • Industry Consumer Products
  • Location Newark, NJ, US
  • Currency USD
  • Founded April 2016
  • Employees 3
  • Incorporation Type C-corp
  • Website sero-clear.com

Company Summary

SeroClear is a different diabetes play. Essentially every other play, in one way or another, manages blood sugar. Diabetic complications are essentially accelerated aging driven by blood sugar. They progress, even with good sugar control. SeroClear is formulated to block complications by clearing the blood of toxic metabolic products of blood sugar.
Regulated as a dietary supplement, SeroClear appeals to the nations 25 million diabetics.

Team

  • Catalyst – finance, entrepreneur, launched internet sales company

  • Benjamin Szwergold, PhD
    Chief Science Officer

    30 yrs of research on biochemistry of diabetes

  • Chief Operating Officer

    industrial science (consumer health, medical diagnostics) with clinical expertise and startup experience

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free